Mycobacterium kansasii infection in a Paris suburb: Comparison of disease presentation and outcome according to human immunodeficiency virus status

International Journal of Tuberculosis and Lung Disease

Volumn 3, Issue 1, 1999, Pages 68-73

  Lortholary, O ^a   Deniel, F ^b   Boudon, P ^c   Le Pennec, M P ^c   Mathieu, M ^c   Soilleux, M ^b   Le Pendeven, C ^d   Loiseau, P ^e   Vincent, V ^f   Valeyre, Dominique ^b,e   Malbec, D ^g   Bentata, M ^g   Fassin, D ^g   Robineau, M ^g   Babinet, P ^g   Blondel, P ^g   Lhote, F ^g   Mechali D ^g   Cruaud, P ^g   Sterin D ^g   Piquet, J ^g   Mellat, M ^g   Echard, M ^g   Mangeol, A ^g   more..

^a Ctr Rech Pathol Infectieuse Trop   (France)

^b UNIVERSITÉ PARIS 13   (France)

^c Centre Hospitalier Robert Ballanger CHRB   (France)

^d Laboratoire Départemental   (France)

^e INSERM   (France)

^f INSTITUT PASTEUR   (France)

^g NONE

Author keywords

AIDS; Chest radiography; Mycobacterium kansasii

Indexed keywords

AMIKACIN; CLARITHROMYCIN; ETHAMBUTOL; ISONIAZID; OFLOXACIN; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN;

ADULT; ARTICLE; BACTERIUM ISOLATION; DIFFERENTIAL DIAGNOSIS; FEMALE; FRANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOBACTERIOSIS; MYCOBACTERIUM KANSASII; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

EID: 0032978227     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Falkinham J O. Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev 1996; 9: 177-215.
2. Levine B, Chaisson R E. Mycobacterium kansasii: a cause of treatable pulmonary disease associated with advanced human immunodeficiency virus (HIV) infection. Ann Intern Med 1991; 114: 861-868.
3. Horsburgh C R Jr, Selik R M. The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). Am Rev Respir Dis 1989; 139: 4-7.
4. Research Committee, British Thoracic Society. Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampicin and ethambutol. Thorax 1994; 49: 442-445.
5. Evans S A, Colville A, Evans A J, Crisp A J, Johnston I D A. Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis. Thorax 1996; 51: 1248-1252.
6. Lillo M, Orengo S, Cernoch P, Harris R L. Pulmonary and disseminated infection due to Mycobacterium kansasii: a decade of experience. Rev Infect Dis 1990; 12: 760-767.
7. Castro K G, Ward J W, Slutsker L, et al. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Clin Infect Dis 1993; 17: 802-810.
8. Carpenter J L, Parks J M. Mycobacterium kansasii infections in patients positive for human immunodeficiency virus. Rev Infect Dis 1991; 13: 789-796.
9. Parenti D M, Symington J S, Keiser J, Simon G I. Mycobacterium kansasii bacteremia in patients infected with human immunodeficiency virus. Clin Infect Dis 1995; 21: 1001-1003.
10. Bamberger D M, Driks M R, Gupta M R, et al. Mycobacterium kansasii among patients infected with human immunodeficiency virus in Kansas City. Clin Infect Dis 1994; 18: 395-400.
11. Witzig R S, Fazal B A, Mera R M, et al. Clinical manifestations and implications of coinfection with Mycobacterium kansasii and human immunodeficiency virus type 1. Clin Infect Dis 1995; 21: 77-85.
12. Surveillance du SIDA en France. Bulletin Épidémiologique Hebdomadaire 1997; 11: 46-49.
13. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997; 156: S1-S25.
14. Inderlied C B, Salfinger M. Antimicrobial agents and susceptibility tests: Mycobacteria. In: Murray P R, Baron E J, Pfaller M A, Tenover F C, Yolken R H. eds. Manual of clinical microbiology. 6th ed. Washington, DC: American Society for Microbiology, 1995: pp 1385-1404.
15. Grosset J, Boisvert H, Truffot-Pernod C. Mycobactéries. In: Le Minor L, Veron M. eds. Bactériologie médicale. 2nd ed. Paris: Médecine Sciences Flammarion, 1989: pp 965-1017.
16. David H, Levy-Frebault V, Thorel M F. Titrage de résistance aux antibiotiques. In: Méthodes de laboratoire pour mycobactériologie clinique. Paris: Institut Pasteur, 1989: 67-71.
17. Boudon P, Le Pennec M P, Malbec D, et al. Infection à Mycobacterium kansasii chez des patients infectés par le virus de l'immunodéficience humaine. Rev Méd Interne 1995; 16: 747-751.
18. 4+ T-lymphocytopenia without HIV infection. An investigation of cases in the United States. N Engl J Med 1993; 328: 373-379.
19. Contreras M A, Cheung O T, Sanders D E, Goldstein R S. Pulmonary infection with nontuberculous mycobacteria. Am Rev Respir Dis 1988; 137: 149-152.
20. O'Brien R J, Geiter E J, Snider D E Jr. The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis 1987; 135: 1007-1014.
21. Al Jarad N, Demertzis P, Meecham Jones D J, et al. Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis. Thorax 1996; 51: 137-139.
22. Banks J, Hunter A M, Campbell I A, Jenkins P A, Smith A P. Pulmonary infection with Mycobacterium kansasii in Wales, 1970-9: review of treatment and response. Thorax 1983; 38: 271-274.
23. Miller W T Jr, Miller W T Sr. Pulmonary infections with atypical mycobacteria in the normal host. Semin Roentgenol 1993; 28: 139-149.
24. Schraufnagel D E, Leech J A, Pollack B. Mycobacterium kansasii: colonization and disease. Br J Dis Chest 1986; 80: 131-136.
25. Ortbals D W, Marr J J. A comparative study of tuberculous and other mycobacterial infections and their associations with malignancy. Am Rev Respir Dis 1978; 117: 39-45.
26. Zvetina J R, Maliwan N, Frederick W E, Reyes C. Mycobacterium kansasii infection following primary pulmonary malignancy. Chest 1992; 102: 10460-1463.
27. Valainis G T, Cardona L M, Greer D L. The spectrum of Mycobacterium kansasii disease associated with HIV-1 infected patients. J Acquir Immune Defic Syndr 1991; 4: 516-520.
28. Campo R E, Campo C E. Mycobacterium kansasii disease in patients infected with human immunodeficiency virus. Clin Infect Dis 1997; 24: 1233-1238.
29. Direction de la Prevention et de l'Action Sociale. La tuberculose dans le département de la Seine-Saint-Denis. Cas déclarés en 1995.
30. Medical Section of The American Lung Association. Mycobacterioses and acquired immunodeficiency syndrome. Am Rev Respir Dis 1987; 136: 492-496.
31. Wallace R J Jr, Dunbar D, Brown B A, et al. Rifampin-resistant Mycobacterium kansasii. Clin Infect Dis 1994; 18: 736-743.
32. Evans A J, Crisp A J, Hubbard R B, Colville A, Evans S A, Johnston I D A. Pulmonary Mycobacterium kansasii infection: comparison of radiological appearances with pulmonary tuberculosis. Thorax 1996; 51: 1243-1247.
33. Fishman J E, Schwartz D S, Sais G J. Mycobacterium kansasii pulmonary infection in patients with AIDS: spectrum of chest radiographic findings. Radiology 1997; 204: 171-175.
34. Schraufnagel D E, Leech J A, Schraufnagel M N, Pollak B. Short-course chemotherapy for Mycobacterium kansasii? Can Med Assoc J 1984; 130: 34-38.
35. Ahn C H, Wallace R J Jr, Steele L C, Murphy D T. Sulfonamide-containing regimens for disease caused by rifampin-resistant Mycobacterium kansasii. Am Rev Respir Dis 1987; 135: 10-16.